No abstract available
Keywords:
ASCT; VTD; multiple myeloma; subcutaneous bortezomib.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Boronic Acids / administration & dosage
-
Bortezomib
-
Dexamethasone / administration & dosage
-
Female
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Male
-
Middle Aged
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / therapy*
-
Peripheral Nervous System Diseases / etiology
-
Prospective Studies
-
Pyrazines / administration & dosage
-
Thalidomide / administration & dosage
-
Transplantation, Autologous
-
Treatment Outcome
Substances
-
Boronic Acids
-
Pyrazines
-
Thalidomide
-
Bortezomib
-
Dexamethasone